Ok, C. Y., Xu-Monette, Z. Y., Tzankov, A., Visco, C., Montes, S. M., Dybkaer, K., … Young, K. H. (2013). STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report Fro The International DLBCL Rituximab-CHOP Consortium Program. In BLOOD (Vol. 122). New Orleans, LA: AMER SOC HEMATOLOGY.

Ok, Chi Young, Zijun Y. Xu-Monette, Alexander Tzankov, Carlo Visco, Santiago M. Montes, Karen Dybkaer, April Chiu, et al. “STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report Fro The International DLBCL Rituximab-CHOP Consortium Program.” In BLOOD, Vol. 122. AMER SOC HEMATOLOGY, 2013.

Ok CY, Xu-Monette ZY, Tzankov A, Visco C, Montes SM, Dybkaer K, et al. STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report Fro The International DLBCL Rituximab-CHOP Consortium Program. In: BLOOD. AMER SOC HEMATOLOGY; 2013.

Ok, Chi Young, et al. “STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report Fro The International DLBCL Rituximab-CHOP Consortium Program.” BLOOD, vol. 122, no. 21, AMER SOC HEMATOLOGY, 2013.

Ok CY, Xu-Monette ZY, Tzankov A, Visco C, Montes SM, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, Van Krieken JHJM, Huang Q, Huh J, Ai WZ, Ponzoni M, Ferreri AJM, Farnen JP, Moller MB, Winter JN, Piris MA, Medeiros LJ, Young KH. STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report Fro The International DLBCL Rituximab-CHOP Consortium Program. BLOOD. AMER SOC HEMATOLOGY; 2013.